Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 24.99% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTOCULAR THERAPEUTIX, INC's latest supported as-filed period reports revenue of $13.5M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 24.99% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -499.24% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 0.12% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 28.39% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 85.08% · CORE
Level · gp.fundamentals.operating_margin
Raw value -609.34% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 0.1%; Operating margin moved 10677 bp lower; Operating income decreased 21.4%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 25.9%; Inventory / revenue moved 581 bp higher.
2 evidence-backed componentsOperating margin changed -10677 basis points from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
OCUL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-104727SEC ↗4Aug 26, 2026Period Aug 24, 20260001104659-26-101674SEC ↗4Aug 26, 2026Period Aug 24, 20260001104659-26-101671SEC ↗4Aug 26, 2026Period Aug 24, 20260001104659-26-101670SEC ↗4Aug 26, 2026Period Aug 24, 20260001104659-26-101667SEC ↗10-QAug 3, 2026Period Jun 30, 20260001104659-26-089450SEC ↗8-KAug 3, 2026Period Aug 3, 20260001104659-26-089443SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 31, 2026Filed Sep 2, 2026 | Notman DonaldChief Operating Officer | Open Market SaleDirect | 1,099 | $10 | $11,254 | Form 4 ↗ |
| Jun 16, 2026Filed Jun 18, 2026 | Dugel PravinSee Remarks | GiftDirect | 50,092 | $0 | $0 | Form 4 ↗ |
| Jun 16, 2026Filed Jun 18, 2026 | Dugel PravinSee Remarks | GiftIndirect | 50,092 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 401.77% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 108.71% · OPTIONAL
Operating income changed -21.4% from the comparable as-filed period.
Cash & equivalents changed +53.1% from the comparable as-filed period.
Stock-based compensation changed +51.4% from the comparable as-filed period.
Inventory / revenue changed +581 basis points from the comparable as-filed period.
SBC / revenue changed +3681 basis points from the comparable as-filed period.
Net income changed -16.1% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-075709